Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer

BACKGROUND: Our previous study reported the favorable efficacy and good tolerance associated with a modified XELOX adjuvant chemotherapy with eight cycles of capecitabine and six cycles of oxaliplatin for operated stage III colon cancer. The current study aimed to confirm the feasibility of modified...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Jianhong, Li, Weihao, Fan, Wenhua, Zhou, Wenhao, Zhu, Ying, Li, Xueying, Pan, Zhizhong, Lin, Xiaoping, Lin, Junzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543913/
https://www.ncbi.nlm.nih.gov/pubmed/33071795
http://dx.doi.org/10.3389/fphar.2020.583091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543913/
https://www.ncbi.nlm.nih.gov/pubmed/33071795
http://dx.doi.org/10.3389/fphar.2020.583091

Ejemplares similares